SCHEMBL19081812

SCHEMBL19081812

c1ccc2cc(-c3c4ccccc4c(-c4cc5c6ccc7ccccc7c6oc5c5sc6ccccc6c45)c4ccccc34)ccc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 10/20 0.42
CYP1B1 Q16678 10/20 0.42
ARSA P15289 1/20 0.35
CDC25A P30304 1/20 0.35
CDC25C P30307 1/20 0.35
S1PR5 Q9H228 4/20 0.35
S1PR4 O95977 3/20 0.35
CYP1A2 P05177 9/20 0.34
ABCB1 P08183 2/20 0.34
ABCC1 P33527 2/20 0.34
ABCG2 Q9UNQ0 2/20 0.34
KDM4E B2RXH2 2/20 0.33
ALDH1A1 P00352 2/20 0.33
HPGD P15428 2/20 0.33
HSD17B10 Q99714 2/20 0.33
PRKDC P78527 2/20 0.33
ALOX15 P16050 1/20 0.33
HTT P42858 1/20 0.33
PSMD14 O00487 1/20 0.33
CSNK2A2 P19784 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081883 0.95 CYP1A1 (0.37) CYP1A1CYP1B1ARSACDC25ACDC25C
SCHEMBL19081955 0.86 CYP1A1 (0.34) CYP1A1CYP1B1ARSACDC25ACDC25C
SCHEMBL19081916 0.86 CYP1A1 (0.38) CYP1A1CYP1B1ARSACDC25ACDC25C
SCHEMBL19076845 0.85 S1PR5 (0.38) CYP1A1CYP1B1ARSACDC25ACDC25C
SCHEMBL19076720 0.85 CYP1A1 (0.38) CYP1A1CYP1B1S1PR5S1PR4PRKDC
SCHEMBL19077670 0.85 CYP1A1 (0.36) CYP1A1CYP1B1ARSACDC25ACDC25C
SCHEMBL19076723 0.84 CYP1A1 (0.37) CYP1A1CYP1B1ARSACDC25ACDC25C
SCHEMBL10122607 0.84 CYP1A1 (0.52) CYP1A1CYP1B1ARSACDC25ACDC25C
SCHEMBL19081846 0.84 CYP1A1 (0.38) CYP1A1CYP1B1S1PR5S1PR4CYP1A2
SCHEMBL19076812 0.84 ALOX5 (0.40) CYP1A1CYP1B1S1PR5S1PR4PRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885ARSA 4543/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885ARSA 4543/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.